How to Buy Cabot Stock
Cabot Corp
Cabot is a specialty chemical company located in Massachusetts, United States, which is part of the Basic Materials sector, and is traded under the ticker CBT on the NYSE exchange.
Cabot stock last closed at $84.10, up 0.63% from the previous day, and has decreased 8.44% in one year. It has overperformed other stocks in the Specialty Chemicals industry by 0.04 percentage points. Cabot stock is currently +5.69% from its 52-week low of $79.57, and -28.4% from its 52-week high of $117.46.
As of Mar 27, 2025, there are 54.22M CBT shares outstanding. The market capitalization of CBT is $4.56B. In the past 24 hours, 309,915 CBT shares were traded.
How to Buy Cabot Stock
Not sure how to invest in Cabot stock? Here's how.
- Figure out where to buy Cabot stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Cabot stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Pick your method of payment and add your details.
- Research Cabot stock: The Cabot ticker symbol is CBT. Is Cabot stock a good investment? Should you buy shares of CBT? How do CBT's underlying business fundamentals look? Do top analysts think Cabot is a good buy? Why has CBT's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if CBT is a good stock to buy).
- Make your CBT buy order: Decide if you will purchase CBT shares at the current market price or use a limit order to purchase CBT stock at a given price.
- Monitor your CBT investment: Create a watchlist to get the latest news on your position in Cabot stock.
Step 1: Figure out where to buy Cabot stock
You need a brokerage account in order to access the NYSE market and buy CBT stock.
Our preferred brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you can buy CBT today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have opened your account on the best stock buying app, you need to deposit funds:
Watch the tutorial below if you need help transferring money into your brokerage account.
Step 4: Research Cabot stock
After you have identified the best place to buy Cabot stock, it's critical to evaluate their stock before you invest, so you truly wrap your head around the risk and opportunity.
Cabot stock at a glance
Cabot Fundamentals
WallStreetZen was built to help part-time investors do better fundamental analysis quickly.
You can view all of the due diligence checks on CBT's stock page.
Is CBT stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CBT's fair value.
Using relative valuations ratios:
- CBT may be undervalued based on its P/E ratio of 11.07x, relative to Specialty Chemicals industry P/E ratio of 28.63x
- CBT may be undervalued based on its P/B ratio of 3.34x, relative to Specialty Chemicals industry P/B ratio of 3.38x
- CBT could be overvalued based on its PEG ratio of 1.71x
You can access additional valuation analysis on CBT's stock here.
CBT Financial Health Overview
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the CBT balance sheet.
- Total CBT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the CBT balance sheet.
- CBT earnings of $618.00M is not sufficient to cover its interest payments.
- CBT's operating cash flow of $711.00M allows it to safely service it's debt of $1.20B.
Negative Financial Indicators:
- CBT has a relatively high debt to equity ratio of 1.56.
- CBT profit margin has gone down from 11.2% to 10.6% in the past year.
Is it a good time to buy CBT stock, according to Wall Street analysts?
Out of 2 Equities analysts who give ratings on CBT, the consensus analyst rating on CBT is a Sell
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Cabot stock forecast page.
CBT Trading Indicators
CBT Growth Metrics
Last year, CBT earnings were $423.00M. Over the last 5 year, CBT's earnings have increased by 28.02% per year. This was faster than the Specialty Chemicals industry average of 14.53%.
Last year, CBT revenue was $3.99B. Over the last five year, CBT's revenue has grown by 4.24% per year. This was slower than the Specialty Chemicals industry average of 4.61%.
Dig into CBT's earnings and revenue performance here.
Are CBT executives and large shareholders buying or selling the stock?
Over the past 12 months, executives and large shareholders at CBT have sold more shares than they have bought.
Lisa M. Dumont, VP Controller CAO of CBT, was the latest CBT insider to sell. They sold $55,389.38 worth of CBT stock on Nov 18, 2024.
Research more about who owns CBT stock here.
Does CBT provide a stable income stream?
Cabot pays a dividend of 1.53%, compared to the Specialty Chemicals industry's average dividend yield of 2.05%. If you owned $1,000 worth of CBT stock, you would have received $15.34 in the past year.
Cabot dividend payments have consistently grown over the past decade and have remained stable.
Get more data about Cabot dividend yield and history here.
What do other investors have to say about CBT?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CBT buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact price, use a limit order.
Hit the Open Trade button and your broker will execute the order.
If you require additional info about buying stocks on eToro, click the how to video below:
Step 6: Monitor your CBT investment
Now that you own some CBT shares, you'll want to keep up with your new stock purchase.
Add CBT to a watchlist to keep tabs on your CBT stock.
CBT Feed
How to Buy Stock in Cabot
To summarize, here are the 6 steps you need to take to buy Cabot stock right now:
- Figure out where to buy Cabot stock
- Open your brokerage account
- Put funds into your brokerage account
- Research Cabot stock
- Make your CBT buy order
- Monitor your CBT investment
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to track your new investment in Cabot, add CBT to your watchlist by clicking the button below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.